Skip to main content

Wildon Farwell

Equibles does not estimate personal net worth.

About Wildon Farwell

Dyne Therapeutics, Inc. reported in an 8-K filed September 3, 2024 that Wildon Farwell resigned as chief medical officer.

“On September 3, 2024, the Company issued a press release announcing the hiring of Doug Kerr as chief medical officer, Johanna Friedl-Naderer as chief commercial officer and Lucia Celona as chief human resources officer and the resignations of Dr. McNeill, Ms. High and Wildon Farwell, the chief medical officer.”
Dyne Therapeutics, Inc. Form 8-K, filed September 3, 2024 · Read the filing

Affiliation history

Company network

Recent activity